ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




1. 8ÔÂ7ÈÕ£¬£¬£¬£¬£¬£¬³É¶¼Íþ˹½òÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾×ÔÖ÷Ñз¢µÄ¡°WGc-043×¢ÉäÒº¡±£¬£¬£¬£¬£¬£¬ÆäÐÂÒ©Ñо¿ÉêÇ루IND£©»ñÅúÁÙ´²ÊÔÑé¡£¡£¡£¡£¡£¡£¡°WGc-043×¢ÉäÒº¡±ÊÇÈ«ÇòÊׯäÖÐÃÀË«±¨¾ù»ñÅúINDµÄÖÎÁÆEB²¡¶¾Ïà¹ØÖ×ÁöµÄmRNAÒßÃç¡£¡£¡£¡£¡£¡£
2. 8ÔÂ7ÈÕ£¬£¬£¬£¬£¬£¬¿µÌ©ÉúÎïͨ¸æ£¬£¬£¬£¬£¬£¬¹«Ë¾Ñз¢µÄËļÛÁ÷¸Ð²¡¶¾ÁѽâÒßÃ磨6¡ª35ÔÂÁäÈËȺ£©¿ËÈÕ»ñµÃ¹ú¼ÒÒ©¼à¾Ö³ö¾ßµÄ¡¶Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡·¡£¡£¡£¡£¡£¡£
3. 8ÔÂ8ÈÕ£¬£¬£¬£¬£¬£¬ÃÀ¹úFDA¹ÙÍøÏÔʾ£¬£¬£¬£¬£¬£¬FDAÒѾÅú׼ŵ»ª£¨Novartis£©¹«Ë¾µÄDZÔÚÖØ°õÁÆ·¨Fabhalta£¨iptacopan£©À©Õ¹Ë³Ó¦Ö¢£¬£¬£¬£¬£¬£¬ÓÃÓÚ½µµÍ³ÉÈËIgAÉö²¡£¡£¡£¡£¡£¡£¨IgAN£©»¼ÕßµÄÂѰ×Äòˮƽ£¬£¬£¬£¬£¬£¬ÕâЩ»¼ÕßÓм²²¡Ñ¸ËÙÏ£ÍûµÄΣº¦¡£¡£¡£¡£¡£¡£FabhaltaÊÇÊ׸öÕë¶ÔÌæ»»²¹Ìåͨ·µÄIgANÁÆ·¨¡£¡£¡£¡£¡£¡£
4. 8ÔÂ7ÈÕ£¬£¬£¬£¬£¬£¬ÎÀÐÅ¿µÍ¨¸æ£¬£¬£¬£¬£¬£¬È«×Ê×Ó¹«Ë¾ÄÚÃɹŰ×Ò½ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾ÊÕµ½¹ú¼ÒÒ©¼à¾ÖÅú׼ǩ·¢µÄ¸Ê¶´¼É½Àæ´¼×¢ÉäÒº¡¶Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡·¡£¡£¡£¡£¡£¡£¸ÃÒ©Æ·ÊÊÓÃÓÚ½µµÍÂÄÚѹºÍÖÎÁÆÄÔË®Öס£¡£¡£¡£¡£¡£
1. 8ÔÂ8ÈÕ£¬£¬£¬£¬£¬£¬ÕýÐòÉúÎïÐû²¼Íê³É³¬ÒÚÔªÈËÃñ±ÒµÄA+ÂÖÈÚ×Ê¡£¡£¡£¡£¡£¡£±¾ÂÖÈÚ×ÊÓÉÉϺ£¹úͶæÚÌÚ×ÊÔ´ÊÂͶ£¬£¬£¬£¬£¬£¬ÁªÐÂ×ÊÔ´¡¢²©Ô£×ÊÔ´¡¢ÀñÀ´ÑÇÖÞ»ù½ð¡¢ÍòÎï×ÊÔ´¡¢ºìɼÖйúµÈÏÖÓйɶ«¸úͶ¡£¡£¡£¡£¡£¡£Æ¾Ö¤ÕýÐòÉúÎïÐÂΟ壬£¬£¬£¬£¬£¬±¾ÂÖÈÚ×ʽ«½øÒ»²½¼ÓËÙCS-101ÁÙ´²Ñо¿ºÍÉÌÒµ»¯Íƽø£¬£¬£¬£¬£¬£¬²¢Ö§³ÖÌåÄÚÖÎÁƹÜÏßµÄÁÙ´²×ª»¯£¬£¬£¬£¬£¬£¬Íƶ¯È«Çò»¯½á¹¹ºÍ»ùÒò±à¼²úÆ·ÔçÈÕÉÏÊС£¡£¡£¡£¡£¡£
1. 8ÔÂ7ÈÕ£¬£¬£¬£¬£¬£¬ÈðµäÎÚÆÕÈøÀ´óѧTobias Sj?blom¡¢Bengt Glimelius¡¢Öйú¿ÆÑ§Ôºº¼ÖÝҽѧÑо¿Ëù/»ª´ó»ùÒòÎâåÓ¼°ÁÖ´ÓÅäºÏͨѶÔÚNature ÔÚÏß½ÒÏþÌâΪ¡°Prognostic genome and transcriptome signatures in colorectal cancers¡±µÄÑо¿ÂÛÎÄ£¬£¬£¬£¬£¬£¬¸ÃÑо¿±¨µÀÁËÈ´Ö±³¦°©µÄÔ¤ºó»ùÒò×éºÍת¼×éÌØÕ÷¡£¡£¡£¡£¡£¡£
[1]Nunes, L., Li, F., Wu, M. et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature (2024). https://doi.org/10.1038/s41586-024-07769-3
Ïà¹ØÐÂÎÅ